3+ day, 7+ hour ago   (387+ words) Fund I will invest across therapeutics, medical devices, diagnostics, and digital health, targeting companies from Series A through growth stages in the US, Europe, and Israel. Luma Group has closed its debut life sciences fund at $410 million, marking another sizable…...

3+ day, 13+ hour ago   (568+ words) Life sciences dealmaking hits record highs as biopharma bets big on early-stage assets amid geopolitical uncertainty. The first half of 2026 has delivered the strongest run of life sciences dealmaking on record, according to a report published by EY - a long-term…...

4+ day, 10+ hour ago   (1031+ words) Three leaders shared how straight talk, low egos, and cost efficiency are turning Scandinavian startups into pharma's trusted collaborators. The Nordic biotech ecosystem could be said to be punching above its weight, and three CEOs at the heart of this…...

5+ day, 5+ hour ago   (229+ words) Four major biopharma companies bring in experienced legal and compliance leaders to strengthen their executive teams this month. Boerneke comes to Aspen from Gossamer Bio, where he served as senior vice president, general counsel, and secretary. He was a member…...

5+ day, 10+ hour ago   (402+ words) Moonwalk Biosciences has closed a $70 million Series B to push adipose-targeted RNAi obesity candidate into the clinic. Moonwalk is developing small interfering RNA (siRNA) therapeutics designed to act directly on adipose tissue, targeting non-incretin biology inside the fat cell itself....

6+ day, 10+ hour ago   (513+ words) The Boston-based biotech has raised an oversubscribed Series B to advance AI-powered GPCR platform and launch its first clinical trial by year-end. The funding aims to propel the company's lead program – a selective, biased melanocortin-4 receptor (MC4R) agonist targeting rare genetic…...

1+ week, 6+ day ago   (609+ words) Research shows pharma companies identify clinical trial risks well but lack the organizational capability to implement effective solutions. Sponsors and CROs are effective at detecting problems with trials, but they are less adept at taking corrective action, according to new…...

2+ week, 4+ day ago   (305+ words) Haisco Pharmaceutical Group has signed a licensing agreement with Sentivera, a newly formed US venture backed by Population Health Partners and ARCH Venture Partners. The deal is valued at over $1.5 billion and will grant Sentivera global rights to develop, manufacture,…...

2+ week, 4+ day ago   (509+ words) Pop star Lady Gaga unveils her board role at Outer Bio, a Massachusetts biotech using human skin tissue to develop new compounds. “Meet Outer Bio and Yuna. We are building the future of skin health,” she wrote on Instagram. Outer…...

2+ week, 5+ day ago   (494+ words) Analysis of trials from 2014 to 2024 reveals cell-based treatments account for nearly half of studies, with small molecules and antibodies trailing. The analysis examined trials of candidate blood cancer treatments listed on ClinicalTrials.gov and Cortellis Drug Discovery Intelligence between 2014 and…...